PharmaPendium is adding new content in the July content update.

FDA Approval Packages:

• 6 new drugs (Collagenase Clostridium Histolyticum, Dalfampridine, Ecallantide, Olanzapine Pamoate, Romidepsin, Velaglucerase Alfa)
• 2,116 new FDA Approval Documents, including documents for 75 Approval Packages
• 50,431 new pages of FDA Approval Documents

FDA Advisory Committee Meeting documents:

• 189,510 pages, 6,019 documents

EMA

• 64,045 pages 3,629 documents

(No EMA update in this release; 1 duplicate file removed)

Extracted Safety data observations:

• 17,139 new extracted data lines for FDA

AERS (post-marketing) reports:

• 355,187 new reports

This brings the new totals for PharmaPendium to the following:

• 1,376,262 pages of FDA Approval documents
• 57,900 FDA Approval documents
• 4,054 Drugs with data in PharmaPendium
• 996,780 extracted data lines in the Drug Safety database
• 3,300,129 AERS (post-marketing) reports
• 3,629 documents / 64,045 pages of EMA Approval documents
• 10,906 documents / 308,015 pages of FDA Classic Collection
• 8,581 documents / 332, 421 pages of FDA Advisory Committee Meeting documents